A prospective, monocentric study to understand the role of inflammatory interleukins in predicting the response to immunosuppressive or biological therapy in inflammatory bowel disease (IBD) patients
Latest Information Update: 18 Feb 2020
At a glance
- Drugs Adalimumab (Primary) ; Azathioprine (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacodynamics
Most Recent Events
- 18 Feb 2020 New trial record